In December 2018, a Russian federal law was passed which stipulates that drugs introduced to the Russian market from July 1, 2020 must be serialised with a crypto-code. In contrast to EU serialisation, this requirement affects all drugs and not only prescription drugs. Lichtenheldt is currently adapting to the additional requirements and will provide [...]
With Directive 2011/62/EU, the European Union launched its initiative against counterfeit medicines. Reliable serialisation and labeling systems for pharmaceutical manufacturers are intended to prevent the trade of illegal prescription drugs. As a European pharmaceutical manufacturer, Lichtenheldt has very successfully implemented the serialisation obligation for all prescription drugs (Rx products) as of February 9, 2019. All [...]
The trade fair of the pharmaceutical industry (CPhI) celebrated its 30th anniversary this year. As an expanding and independent contract manufacturer, Lichtenheldt GmbH was of course also represented this year with a large exhibition stand in order to present the wide range of products and services to the visitors. For over 70 years, Lichtenheldt [...]
As a basis for our corporate culture 6 new company values were defined. These values have been interpreted and for daily practical use translated by the executive team and a representative number of employees of all departments. As a harmonized result, a new value-guide has been issued and presented to all employees on 14th of [...]
As a modern and progressive company, we want to be both a competent partner for our customers and an attractive employer for our employees and potential applicants. Therefore, as of now we are present with a profile in the social media sites XING, LinkedIn and Facebook. Please visit us and follow our activities also here. [...]
Lichtenheldt GmbH, a family-run, medium-sized company, uses the support of the ERDF to expand internationalisation in the EU domestic market and to position itself beyond national borders as a reliable partner in the field of contract manufacturing of pharmaceutical and dietary supplements. Our goal is to make a decisive contribution to securing the supply of [...]
We presented ourselves to an international audience at the CPhI from 24-26 October with a newly designed exhibition stand. Our cross-divisional consulting team consisting of sales, manufacturing and product development represented Lichtenheldt as a reliable and competent contract manufacturer in an outstanding way. Our service portfolio was presented to numerous new interested parties and customers [...]
On September 20, Lichtenheldt focused on health. Together with the cooperation partners BARMER, TALINGO EAP Service and the employers' liability insurance association RCI, an eventful health day was designed to promote healthy lifestyle and behavior in everyday life. The versatile information & tips on physical and mental health were received with great attention and the [...]
With a company profile, Lichtenheldt presents itself as an experienced and reliable expert in the pharmind 8.2017 when it comes to contract manufacturing and development for liquid and semi-solid non-sterile finished products. To the article -> https://lichtenheldt.de/wp-content/uploads/2017/09/PI7908_1061_Uprofil-Lichtenheldt-GmbH-08-17_engl_Fass.pdf
By extending our range of education we underline our commitment to enable young professionals. As from August 2018 we offer two apprenticeships in pharmaceutical production. The complete overview of apprenticeship training positions you find here. As accredited training center our authorized instructor Dr. Danilo Froriep qualifys pharmacists to experts for pharmaceutical analytics.
